Home Newsfeeds Dawson James Downgrades Aditxt to Neutral

Dawson James Downgrades Aditxt to Neutral

Dawson James analyst Jason Kolbert downgrades Aditxt (NASDAQ:ADTX) from Buy to Neutral.

byBenzinga Newsdesk

September 16, 2022

1 minute read

Dawson James analyst Jason Kolbert downgrades Aditxt (NASDAQ:ADTX) from Buy to Neutral.

Barclays Maintains Equal-Weight on Jack In The Box, Raises Price Target to $84

By Benzinga Newsdesk

March 2, 7:39 AM

Barclays analyst Jeffrey Bernstein maintains Jack In The Box (NASDAQ:JACK) with a Equal-Weight and raises the price target from $73 to $84.

JACK

What’s New For Rivian’s R1T And R1S Next Year? Leaked Documents Hint At Efficiency Boost With Heat Pump, Battery Suprise

By Anan Ashraf

May 22, 4:17 AM

Rivian might opt to shift to lithium iron phosphate batteries in its Standard battery packs to lower costs, as per the report.

RIVN

Wall Street To Snap Longest Winning Streak Since 2021 Today? Earnings, Bond Yields In Focus Ahead Of Powell’s Speech

By Shanthi Rexaline

November 9, 8:25 AM

The stock market’s momentum appears to be waning, and futures suggest a mixed opening for Thursday. Earnings reports have generally been positive, with companies like Walt Disney Co.

AFRM

Barclays Maintains Overweight on Avantor, Lowers Price Target to $30

By Benzinga Newsdesk

September 12, 6:46 AM

Barclays analyst Luke Sergott maintains Avantor (NYSE:AVTR) with a Overweight and lowers the price target from $33 to $30.

AVTR

Dawson James Downgrades Aditxt to Neutral

Related Posts

Barclays Maintains Equal-Weight on Jack In The Box, Raises Price Target to $84

What’s New For Rivian’s R1T And R1S Next Year? Leaked Documents Hint At Efficiency Boost With Heat Pump, Battery Suprise

Wall Street To Snap Longest Winning Streak Since 2021 Today? Earnings, Bond Yields In Focus Ahead Of Powell’s Speech

Barclays Maintains Overweight on Avantor, Lowers Price Target to $30